David Saxon Analyst PerformanceMedical Technologies Equity Research at Needham & Company LLCDavid Saxon is a stock analyst at Needham & Company LLC in the healthcare sector, covering 21 publicly traded companies. Over the past year, David Saxon has issued 53 stock ratings, including buy and hold recommendations. While full access to David Saxon's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Saxon's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings127 Last 6 YearsBuy Recommendations79.53% 101 Buy RatingsCompanies Covered21 Unique Companies Ratings Distribution127RatingsDistribution of strong buy, buy, hold, and sell ratings by David Saxon.RatingPercentageCount Strong Buy0.0%0 ratings Buy79.5%101 ratings Hold20.5%26 ratings Sell0.0%0 ratingsOut of 127 total stock ratings issued by David Saxon at Needham & Company LLC, the majority (79.5%) have been Buy recommendations, followed by 20.5% Hold.Best & Worst CallsBest Call0000.0%CYRXMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%RXSTApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ71.4% of companies on NASDAQ15 companiesNYSE28.6% of companies on NYSE6 companiesDavid Saxon, an analyst at Needham & Company LLC, currently covers 21 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare21 companies100.0%David Saxon of Needham & Company LLC specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageHEALTHCARE EQUIPMENT & SUPPLIES19 companies90.5%LIFE SCIENCES TOOLS & SERVICES2 companies9.5% About David SaxonDavid Saxon joined Needham & Company in 2017 covering medical technologies. Prior to joining Needham, David worked in asset management at firms including Merrill Lynch and Baker Avenue Asset Management. David holds an MBA from Boston University’s Questrom School of Business and a BA in Economics from Boston University. David is a CFA charterholder.Follow on LinkedIn David Saxon's Ratings History at Needham & Company LLC Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsGEHCGE HealthCare Technologies10/5/2026Reiterated Rating$64.99$93.00Buy$0.0000.00% ROIIRTCiRhythm Technologies10/5/2026Boost Price Target$109.35$194.00Buy$0.0000.00% ROIIRMDiRadimed9/22/2026Initiated Coverage$82.46Hold$0.0000.00% ROIBFLYButterfly Network9/22/2026Initiated Coverage$8.14$10.00Buy$0.0000.00% ROIGEHCGE HealthCare Technologies9/22/2026Initiated Coverage$64.81$93.00Buy$0.0000.00% ROIBFLYButterfly Network9/22/2026Initiated Coverage$9.93$10.00Buy$0.0000.00% ROIGEHCGE HealthCare Technologies9/22/2026Initiated Coverage$66.27$93.00Buy$0.0000.00% ROINVSTEnvista9/18/2026Reiterated Rating$23.72Hold$0.0000.00% ROIBLCOBausch + Lomb9/15/2026Reiterated Rating$17.64Hold$0.0000.00% ROIALCAlcon9/15/2026Reiterated Rating$67.71$98.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. AZTAAzenta9/14/2026Reiterated Rating$30.29$37.00Buy$0.0000.00% ROICOOCooper Companies9/10/2026Lower Price Target$63.48$73.00Buy$0.0000.00% ROIALCAlcon8/11/2026Boost Price Target$75.06$98.00Buy$0.0000.00% ROIIRTCiRhythm Technologies8/7/2026Lower Price Target$128.12$192.00Buy$0.0000.00% ROICYRXCryoPort8/7/2026Boost Price Target$14.71$19.00Buy$0.0000.00% ROIAZTAAzenta8/5/2026Boost Price Target$30.76$37.00Buy$0.0000.00% ROIGKOSGlaukos7/30/2026Boost Price Target$161.97$201.00Buy$0.0000.00% ROIRXSTRxSight7/7/2026Reiterated Rating$5.60$11.00Buy$0.0000.00% ROICARLCarlsmed7/1/2026Initiated Coverage$10.38$17.00Buy$0.0000.00% ROIGKOSGlaukos6/17/2026Boost Price Target$127.60$150.00Buy$0.0000.00% ROICOOCooper Companies6/5/2026Lower Price Target$62.02$86.00Buy$0.0000.00% ROIGMEDGlobus Medical5/8/2026Boost Price Target$85.05$117.00Buy$0.0000.00% ROIRXSTRxSight5/7/2026Lower Price Target$6.78$11.00Buy$0.0000.00% ROIATECAlphatec5/6/2026Lower Price Target$10.23$14.00Buy$0.0000.00% ROIALCAlcon5/6/2026Reiterated Rating$74.43$100.00Buy$0.0000.00% ROIAZTAAzenta5/6/2026Lower Price Target$18.38$33.00Buy$0.0000.00% ROICYRXCryoPort5/5/2026Boost Price Target$10.21$15.00Buy$0.0000.00% ROIIRTCiRhythm Technologies5/1/2026Boost Price Target$129.16$255.00Buy$0.0000.00% ROIGKOSGlaukos4/30/2026Boost Price Target$116.94$136.00Buy$0.0000.00% ROIAZTAAzenta3/17/2026Reiterated Rating$20.91$44.00Buy$0.0000.00% ROICOOCooper Companies3/6/2026Boost Price Target$80.20$101.00Buy$0.0000.00% ROICYRXCryoPort3/4/2026Boost Price Target$8.49$13.00Buy$0.0000.00% ROIRXSTRxSight2/26/2026Reiterated Rating$8.81$13.00Buy$0.0000.00% ROIALCAlcon2/26/2026Boost Price Target$86.27$100.00Buy$0.0000.00% ROIGMEDGlobus Medical2/25/2026Boost Price Target$92.01$114.00Buy$0.0000.00% ROIGKOSGlaukos2/18/2026Boost Price Target$107.08$127.00Buy$0.0000.00% ROIAZTAAzenta2/4/2026Reiterated Rating$28.73$44.00Buy$0.0000.00% ROICOOCooper Companies2/3/2026Lower Price Target$80.65$99.00Buy$0.0000.00% ROIGMEDGlobus Medical1/30/2026Upgrade$90.20$112.00Buy$0.0000.00% ROIGKOSGlaukos1/14/2026Reiterated Rating$110.09$125.00Buy$0.0000.00% ROISmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (Ad)A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.Click here to learn this company's name for free todayIRTCiRhythm Technologies1/12/2026Reiterated Rating$179.43$244.00Buy$0.0000.00% ROIATECAlphatec1/12/2026Reiterated Rating$17.92$22.00Buy$0.0000.00% ROIAZTAAzenta12/19/2025Boost Price Target$34.50$44.00Buy$0.0000.00% ROISIBNSiBone12/16/2025Boost Price Target$18.41$27.00Buy$0.0000.00% ROIGKOSGlaukos12/9/2025Boost Price Target$108.48$125.00Buy$0.0000.00% ROICOOCooper Companies12/5/2025Reiterated Rating$77.03$100.00Buy$0.0000.00% ROIAZTAAzenta11/21/2025Boost Price Target$34.89$42.00Buy$0.0000.00% ROIALCAlcon11/12/2025Lower Price Target$77.55$98.00Buy$0.0000.00% ROIRXSTRxSight11/6/2025Boost Price Target$8.34$12.00Buy$0.0000.00% ROICYRXCryoPort11/5/2025Boost Price Target$9.22$12.00Buy$0.0000.00% ROIIRTCiRhythm Technologies10/31/2025Boost Price Target$184.12$244.00Buy$0.0000.00% ROIATECAlphatec10/31/2025Boost Price Target$16.33$22.00Buy$0.0000.00% ROIGKOSGlaukos10/30/2025Boost Price Target$77.27$117.00Buy$0.0000.00% ROIXRAYDENTSPLY SIRONA9/26/2025Reiterated Rating$12.37Hold$0.0000.00% ROIIRTCiRhythm Technologies8/28/2025Boost Price Target$169.79$193.00Buy$000.0000.00% ROICOOCooper Companies8/28/2025Reiterated Rating$74.11$94.00Buy$00.0000.00% ROISGHTSight Sciences8/28/2025Reiterated Rating$4.07Hold$0.0000.00% ROIALCAlcon8/20/2025Reiterated Rating$90.14$107.00Buy$00.0000.00% ROIALCAlcon8/13/2025Reiterated Rating$86.03$107.00Buy$00.0000.00% ROIRXSTRxSight8/8/2025Lower Price Target$7.79$11.00Buy$0.0000.00% ROIIRTCiRhythm Technologies8/1/2025Boost Price Target$140.18$180.00Buy$000.0000.00% ROIGMEDGlobus Medical7/21/2025Reiterated Rating$52.97Hold$00.0000.00% ROIXRAYDENTSPLY SIRONA7/21/2025Reiterated Rating$15.88Hold$00.0000.00% ROIRXSTRxSight7/9/2025Reiterated Rating$12.79$22.00Buy$0.0000.00% ROICOOCooper Companies6/17/2025Upgrade$69.74$94.00Buy$00.0000.00% ROICOOCooper Companies5/22/2025Reiterated Rating$79.37Hold$00.0000.00% ROISTAASTAAR Surgical5/21/2025Reiterated Rating$19.24Hold$00.0000.00% ROIALCAlcon5/14/2025Reiterated Rating$93.48$110.00Buy$00.0000.00% ROICYRXCryoPort5/8/2025Reiterated Rating$5.66$11.00Buy$00.0000.00% ROIAZTAAzenta5/7/2025Lower Price Target$25.27$40.00Buy$00.0000.00% ROISIBNSiBone5/6/2025Reiterated Rating$14.25$24.00Buy$00.0000.00% ROIIRTCiRhythm Technologies5/2/2025Boost Price Target$108.59$151.00Buy$000.0000.00% ROIATECAlphatec5/2/2025Reiterated Rating$11.06$16.00Buy$00.0000.00% ROIGKOSGlaukos5/1/2025Lower Price Target$94.42$115.00Buy$000.0000.00% ROIALGNAlign Technology5/1/2025Reiterated Rating$173.30Hold$000.0000.00% ROIBLCOBausch + Lomb4/24/2025Reiterated Rating$13.56Hold$00.0000.00% ROICYRXCryoPort4/16/2025Reiterated Rating$5.56$11.00Buy$00.0000.00% ROICYRXCryoPort4/10/2025Reiterated Rating$5.36$11.00Buy$0.0000.00% ROISGHTSight Sciences4/9/2025Reiterated Rating$2.09Hold$0.0000.00% ROIRXSTRxSight4/3/2025Reiterated Rating$26.12$43.00Buy$0.0000.00% ROICYRXCryoPort3/31/2025Reiterated Rating$6.65$11.00Buy$0.0000.00% ROIALCAlcon3/28/2025Boost Price Target$96.95$110.00Buy$00.0000.00% ROIALCAlcon3/20/2025Reiterated Rating$90.89$107.00Buy$00.0000.00% ROIGMEDGlobus Medical3/18/2025Reiterated Rating$72.16Hold$00.0000.00% ROIXRAYDENTSPLY SIRONA3/13/2025Reiterated Rating$15.33Hold$00.0000.00% ROIZIMVZimVie3/13/2025Reiterated Rating$12.65Hold$0.0000.00% ROICOOCooper Companies3/7/2025Reiterated Rating$90.98Hold$00.0000.00% ROINVSTEnvista3/6/2025Reiterated Rating$18.28Hold$00.0000.00% ROISGHTSight Sciences3/6/2025Reiterated Rating$2.42Hold$0.0000.00% ROICYRXCryoPort3/5/2025Reiterated Rating$5.06$11.00Buy$0.0000.00% ROIMy top 3 AI picks for the next decade (Ad)Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.Click here to get all three AI stock names from Alexander GreenXRAYDENTSPLY SIRONA2/28/2025Lower Price Target$17.15$23.00Buy$00.0000.00% ROISTAASTAAR Surgical2/27/2025Reiterated Rating$17.09Hold$00.0000.00% ROIZIMVZimVie2/27/2025Reiterated Rating$13.10$23.00Buy$0.0000.00% ROIATECAlphatec2/27/2025Reiterated Rating$11.06$16.00Buy$00.0000.00% ROIRXSTRxSight2/26/2025Reiterated Rating$29.21$43.00Buy$0.0000.00% ROIALCAlcon2/26/2025Reiterated Rating$91.27$106.00Buy$00.0000.00% ROINVSTEnvista2/25/2025Reiterated Rating$21.36Hold$00.0000.00% ROISIBNSiBone2/25/2025Boost Price Target$17.47$24.00Buy$00.0000.00% ROIGKOSGlaukos2/21/2025Boost Price Target$157.97$176.00Buy$000.0000.00% ROIIRTCiRhythm Technologies2/21/2025Boost Price Target$112.34$138.00Buy$000.0000.00% ROIGMEDGlobus Medical2/21/2025Reiterated Rating$84.22Hold$00.0000.00% ROIBLCOBausch + Lomb2/20/2025Reiterated Rating$16.29Hold$00.0000.00% ROISTAASTAAR Surgical2/12/2025Reiterated Rating$21.88Hold$00.0000.00% ROIXRAYDENTSPLY SIRONA2/11/2025Reiterated Rating$18.37$25.00Buy$00.0000.00% ROINVSTEnvista2/6/2025Reiterated Rating$20.58Hold$00.0000.00% ROIAZTAAzenta2/6/2025Boost Price Target$53.76$59.00Buy$00.0000.00% ROIGMEDGlobus Medical2/6/2025Reiterated Rating$88.32Hold$00.0000.00% ROIXRAYDENTSPLY SIRONA1/30/2025Boost Price Target$19.63$25.00Buy$00.0000.00% ROIALCAlcon1/24/2025Lower Price Target$89.12$106.00Buy$00.0000.00% ROICYRXCryoPort1/17/2025Reiterated Rating$7.47$11.00Buy$00.0000.00% ROISGHTSight Sciences1/14/2025Reiterated Rating$3.29Hold$0.0000.00% ROIRXSTRxSight1/13/2025Reiterated Rating$33.43$66.00Buy$00.0000.00% ROISIBNSiBone1/13/2025Reiterated Rating$15.66$19.00Buy$00.0000.00% ROIATECAlphatec1/13/2025Boost Price Target$11.43$16.00Buy$00.0000.00% ROIIRTCiRhythm Technologies1/13/2025Boost Price Target$92.90$112.00Buy$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
